ICC staining assay revealed that the expression of CDH2 and Vim were decreased after blocking CD44 expression in K-RAS-overexpressing U87MG cells, which further confirm that K-RAS/ERK/CD44 axis regulated the invasiveness and stemness of IR-treated GBM cells (Figure 3N). The gene discussed is KRAS; the disease is glioblastoma.